Timothy J. Eberlein

11.9k citations
201 papers · 9.1k · 2 hit papers · h-index 48

Impact in

  • Immunology top 0.5%
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction
    • T-cell and B-cell Immunology
    • Immune cells in cancer
  • Oncology top 0.5%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research

Papers in

    • Cancer Immunotherapy and Biomarkers 23
    • CAR-T cell therapy research 21
    • Immunotherapy and Immune Responses 60
    • Immune Cell Function and Interaction 31
    • T-cell and B-cell Immunology 16

Timothy J. Eberlein

191 papers receiving 8.7k citations

Timothy J. Eberlein's Hit Papers

Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis 2013 · 493 citations
4930+8+16Years since publication4008001.2k

Peers

Timothy J. Eberlein
Comparison fields: 5 of 138
  • Immunology 3.7k
  • Oncology 3.4k
  • Cancer Research 1.7k
  • Pathology and Forensic Medicine 895
  • Pulmonary and Respiratory Medicine 842
Replace Douglas W. Blayney with:
Douglas W. Blayney United States
Nelson J. Chao United States
Jonathan S. Berek United States
John T. Vetto United States
Ingo G.H. Schmidt‐Wolf Germany
Christian Marth Austria
Norma K.C. Ramsay United States
Harold J. Wanebo United States
James L.M. Ferrara United States
Nicola Silvestris Italy
Timothy J. Eberlein relative to Douglas W. Blayney United States Douglas W. Blayney's profile →
Citations per field
00.5×1.5×2.0×
Douglas W. Blayney · 1×
Citations per year

Countries citing papers authored by Timothy J. Eberlein

Since Specialization
Citations

This map shows the geographic impact of Timothy J. Eberlein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy J. Eberlein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy J. Eberlein more than expected).

Fields of papers citing papers by Timothy J. Eberlein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy J. Eberlein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy J. Eberlein. The network helps show where Timothy J. Eberlein may publish in the future.

Co-authors

The 25 scholars most cited alongside Timothy J. Eberlein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Timothy J. Eberlein Line = papers co-authored together Timothy J. Eberlein links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 201 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Prevalence of Regulatory T Cells Is Increased in Peripheral Blood and Tumor Microenvironment of Patients with Pancreas or Breast Adenocarcinoma
Hit paper breakdown →
20021245
2
Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis
Hit paper breakdown →
2013493
3 1994400
4 2009362
5 1996276
6 2007260
7 1995250
8 1994180
9
HER2/neu-derived peptides are shared antigens among human non-small cell lung cancer and ovarian cancer.
1994154
10 2007152
11 2008142
12
Expression and function of galectin-3, a beta-galactoside-binding protein in activated T lymphocytes.
2001139
13 2012139
14 1995128
15 2006124
16 1991124
17 2001122
18 2010117
19 1996109
20 1993108

About Timothy J. Eberlein

Timothy J. Eberlein is a scholar working on Oncology, Immunology, Cancer Research, Surgery and Pulmonary and Respiratory Medicine, having authored 201 papers that have together received 9.1k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (60 papers), Breast Cancer Treatment Studies (37 papers), Immune Cell Function and Interaction (31 papers), Cancer Immunotherapy and Biomarkers (23 papers), CAR-T cell therapy research (21 papers), T-cell and B-cell Immunology (16 papers), Monoclonal and Polyclonal Antibodies Research (14 papers) and Breast Lesions and Carcinomas (14 papers). The work is most often cited by research in Immunology (3.7k citations), Oncology (3.4k citations), Cancer Research (1.7k citations), Pathology and Forensic Medicine (895 citations) and Pulmonary and Respiratory Medicine (842 citations). Timothy J. Eberlein has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Peter S. Goedegebuure, David C. Linehan, Hong‐Gu Joo, William E. Gillanders, Udaya Liyanage, Todd T. Moore, Yoshiyuki Tanaka, George E. Peoples, Rebecca Aft and Julie A. Margenthaler. Their work appears in journals such as Annals of Surgery, Annals of Surgical Oncology, The Journal of Immunology, Surgery and International Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact